Inactivated whole-cell bacterial vaccines: current status and novel strategies (Q47611164)

4 February 2018

review article

1 reference

title

Inactivated whole-cell bacterial vaccines: current status and novel strategies (English)

1 reference

4 February 2018

author name string

Pace JL

1

1 reference

4 February 2018

Rossi HA

2

1 reference

4 February 2018

Esposito VM

3

1 reference

4 February 2018

Frey SM

4

1 reference

4 February 2018

Tucker KD

5

1 reference

4 February 2018

Walker RI

6

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 October 1998

1 reference

4 February 2018

published in

Vaccine

1 reference

4 February 2018

volume

16

1 reference

4 February 2018

issue

16

1 reference

4 February 2018

page(s)

1563-1574

1 reference

4 February 2018

Epidemiology of drug resistance: implications for a post-antimicrobial era

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

The crisis in antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Travel and the emergence of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Approaches to limiting emergence of antimicrobial resistance in bacteria in human populations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Vaccination against enteric bacterial diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Mucosal immunity: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

1993 Colworth Prize Lecture. The molecular basis for the virulence of bacterial pathogens: implications for oral vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Antigens in whooping cough vaccine and antibody levels induced by vaccination of children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Gut mucosal, salivary and serum antitoxic and antibacterial antibody responses in Swedes after oral immunization with B subunit-whole cell cholera vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Bordetella pertussis whole cell vaccines--efficacy and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

The protection of infant mice from colonization with Campylobacter jejuni by vaccination of the dams

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Field Trial of Oral Cholera Vaccines in Bangladesh: Results of One Year of Follow-Up

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Immunoprotective oral whole cell vaccine for enterotoxigenic Escherichia coli diarrhea prepared by in situ destruction of chromosomal and plasmid DNA with colicin E2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Comparison of different vaccines and induced immune response against Campylobacter jejuni colonization in the infant mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Oral cholera vaccines containing B-subunit-killed whole cells and killed whole cells only. II. Field evaluation of cross-protection against other members of the Vibrionaceae family.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Effect of oral immunization with Pseudomonas aeruginosa on the development of specific antibacterial immunity in the lungs.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Protective immunity in mouse salmonellosis: comparison of smooth and rough live and killed vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Protection against recurrent acute bronchitis after oral immunization with killed Haemophilus influenzae.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Reduction in the Incidence of Acute Bronchitis by an OralHaemophilus influenzaeVaccine in Patients with Chronic Bronchitis in the Highlands of Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Antibody responses after immunization with killed oral cholera vaccines during the 1985 vaccine field trial in Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Difference in the Protection against Infection with Different Challenge Strains of Salmonella enteritidis by Killed Vaccin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae O1 infections in a cholera-endemic area

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Bacterial vaccines: old and new, veterinary and medical

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Killed Campylobacter elicits immune response and protection when administered with an oral adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Safety and immunogenicity of the oral, whole cell/recombinant B subunit cholera vaccine in North American volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Community-based assessment of safety and immunogenicity of the whole cell plus recombinant B subunit (WC/rBS) oral cholera vaccine in Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Pulmonary immunity to Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Systemic and mucosal intestinal antibody response of sheep immunized with aromatic-dependent live or killed Salmonella typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

The effects of vaccination with inactivated uropathogenic bacteria in recurrent urinary tract infections of children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Vaccination with a formalin-killed P-fimbriated E. coli whole-cell vaccine prevents renal scarring from pyelonephritis in the non-human primate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Circulating cholera antitoxin memory cells in the blood one year after oral cholera vaccination in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

IgG and IgA Subclass Distribution of Antitoxin Antibody Responses after Oral Cholera Vaccination or Cholera Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Experimental evaluation of antitoxic protective effect of new cholera vaccines in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Major outer membrane proteins of Vibrio cholerae and their role in induction of protective immunity through inhibition of intestinal colonization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Virulence factors of enterotoxigenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Local and systemic antibody response in infants after oral administration of inactivated enteropathogenic E. coli serotype O111 and O55.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Local vaccination with killed Streptococcus uberis protects the bovine mammary gland against experimental intramammary challenge with the homologous strain.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Vaccine containing iron-regulated proteins of Pasteurella haemolytica A2 enhances protection against experimental pasteurellosis in lambs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Analysis of immunization route-related variation in the immune response to heat-killed Salmonella typhimurium in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Environmental signals controlling expression of virulence determinants in bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Kinetic and antigenic characterization of altered protein synthesis by Campylobacter jejuni during cultivation with human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Detection and differentiation of iron-responsive avirulent mutants on Congo red agar

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

The Vwa+ Virulence Factor of Yersiniae: The Molecular Basis of the Attendant Nutritional Requirement for Ca++

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Virulence of iron transport mutants of Shigella flexneri and utilization of host iron compounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

In vitro simulation of in vivo conditions: physical state of the culture medium

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Temperature regulation of virulence genes in pathogenic bacteria: a general strategy for human pathogens?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Coordinate regulation and sensory transduction in the control of bacterial virulence

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Expression of Salmonella typhimurium genes required for invasion is regulated by changes in DNA supercoiling

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

The Yersinia pestis V antigen is a regulatory protein necessary for Ca2(+)-dependent growth and maximal expression of low-Ca2+ response virulence genes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Temperature-regulated expression of invasion genes inShigella flexneriis controlled through the transcriptional activation of thevirBgene on the large plasmid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Morphological and cytoskeletal changes in epithelial cells occur immediately upon interaction with Salmonella typhimurium grown under low-oxygen conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Contact with epithelial cells induces the formation of surface appendages on Salmonella typhimurium

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Regulation by Ca2+ in the Yersinia low-Ca2+ response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Regulation of cholera toxin by temperature, pH, and osmolarity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Growth phase and low pH affect the thermal regulation of the Yersinia enterocolitica inv gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

The three Bacillus anthracis toxin genes are coordinately regulated by bicarbonate and temperature.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Environmental modulation of gene expression and pathogenesis in Yersinia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Genetics and regulation of heme iron transport in Shigella dysenteriae and detection of an analogous system in Escherichia coli O157:H7.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Modulation of horizontal gene transfer in pathogenic bacteria by in vivo signals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Effect of bile on Vibrio parahaemolyticus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Involvement of the epidermal growth factor receptor in the invasion of cultured mammalian cells by Salmonella typhimurium

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Calcium in bacteria: a solution to which problem?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Congo red binding phenotype is associated with hemin binding and increased infectivity of Shigella flexneri in the HeLa cell model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Iron acquisition in the pathogenic Neisseria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Molecular and functional characterization of the Salmonella invasion gene invA: homology of InvA to members of a new protein family

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

A Campylobacter jejuni homolog of the LcrD/FlbF family of proteins is necessary for flagellar biogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Identification of two targets of the type III protein secretion system encoded by the inv and spa loci of Salmonella typhimurium that have homology to the Shigella IpaD and IpaA proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

New strategies for using mucosal vaccination to achieve more effective immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Development of oral vaccines against enterotoxinogenic Escherichia coli diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Laboratory and field trial assessment of protection given by a Salmonella enteritidis PT4 inactivated, adjuvant vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Field trial of oral cholera vaccines in Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

An oral B subunit: whole cell vaccine against cholera

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Evaluation of different immunization schedules for oral cholera B subunit-whole cell vaccine in Swedish volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Oral cholera vaccines containing B-subunit-killed whole cells and killed whole cells only. I. Cross-reacting antigens of members of family Vibrionaceae and the vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Field trial of a locally produced, killed, oral cholera vaccine in Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Attack rates of notified whooping cough in immunised and unimmunised children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Whooping cough and whooping cough vaccine: the risks and benefits debate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

A controlled trial of a killed Haemophilus influenzae vaccine for prevention of acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

New 23-valent pneumococcal vaccine in relation to pneumococcal serotypes in systemic and non-systemic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Glutaraldehyde in whole-cell Bordetella pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Glutaraldehyde inactivated pertussis vaccine: a less histamine sensitizing vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Studies on the optimal conditions for inactivation of Bordetella pertussis organisms with glutaraldehyde for preparation of a safe and potent pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

The detoxification of Bordetella pertussis with glutaraldehyde

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Acetone-treated pertussis vaccine--a potent and safer new pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Effect of chemical and heat inactivation on the antigenicity and immunogenicity of Vibrio cholerae.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

Influence of strain viability and antigen dose on the use of attenuated mutants of Salmonella as vaccine carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900046-2

7 January 2021

10.1016/S0264-410X(98)00046-2

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018